Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...

A Fort Worth hospital is participating in an international study to help more people survive cardiac arrest.

Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

The Watford Observer reports that Calafiori has influenced Bove’s decision to head to Vicarage Road. The pair grew up together in Roma and Italy youth sides. Bove ended his Roma contract because ...

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...

From heart troubles to an eligibility battle, here's how the Gonzaga forward kept his playing career alive.

Edoardo Bove has officially signed a long-term contract with Watford, after terminating his Roma deal due to a heart ...

This has been a saga. City won the day in the end, taking their January spending beyond the £80m mark and boosting their ...

Bove looks set to join Watford from Roma, 13 months after suffering a cardiac arrest on the pitch while playing for ...

Some specialists believe there’s an even easier solution. Manuel Martínez-Sellés, head of Acute Cardiac Care at Madrid’s ...

Juniper Biomedical announces that Neuropace founder Frank Fischer joins BOD and that the company won the Phase 3 of the NIH ...

Trinity Health Ann Arbor has completed Michigan’s first implant of the world’s smallest device designed to help treat ...